Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Further Reading from MarketBeat 3 Blue-Chip Stocks Built for a Rotating MarketReported by Chris Markoch. Article Published: 3/8/2026. 
In Brief - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
Sector rotation occurs when investors move money out of market sectors that look overbought and into ones that seem undervalued. In 2026, that has meant rotating away from mega-cap technology stocks and into value-oriented names, particularly defensive sectors such as energy and consumer staples. The key word is overvalued. Big tech has run hot for more than two years, largely driven by the emergence of artificial intelligence (AI). Despite talk of a dot-com–style bubble, investors largely ignored the lofty valuations on many of these names. Investors who believed "this time is different" are discovering that valuation doesn't matter until it does. As the economy heats up, buyers are looking for value elsewhere — including blue-chip defensive names like the stocks listed here. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a major utility provider in the Southeast and Midwest United States. Utilities are typically considered value and income stocks, and Duke offers an attractive, secure dividend yielding around 3.2%. The company has raised its dividend for 20 consecutive years. The U.S. energy landscape is also opening a window for future growth at DUK. The company follows an "all-of-the-above" approach to generation, including nuclear, hydroelectric and natural gas. Natural gas has helped drive the stock's strong bounce in 2026. Still, it's Duke's stable residential utility revenue, combined with projected growth from areas such as data centers, that makes DUK a sector-rotation target. DUK is up nearly 12% in 2026, placing it within about 5% of the consensus price target of $136.87, which would push the stock above its 52-week high. Trading at roughly 20.5x earnings, the shares sit at a slight premium to their historical average. Since reporting earnings in February, analysts have been raising their price targets on expectations of strong year-over-year revenue growth in the second half of the year — a shift that could prompt a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Some analysts expect biotechnology to benefit from the current rotation. Gilead Sciences (NASDAQ: GILD) offers defensive growth within healthcare, a sector that has generally lagged the broader market. Gilead is a leading provider of HIV therapies, with key drugs protected by patents into the 2030s. Investors are also encouraged by a pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026, and it may see a label expansion for Trodelvy, its breast cancer drug. GILD is up nearly 18% in 2026, which pushed the stock to a 52-week high. It's slightly off that level now, likely due to profit-taking after the outsized run-up — a pullback that could present a buy-the-dip opportunity. Analysts' consensus price target of $156.72 implies a gain of roughly 8%. Since Gilead's February earnings, many analysts have raised targets, with the highest estimates near $170. Gilead also pays a reliable dividend, yielding about 2.28%, and has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) has been one of the bigger beneficiaries of the rotation into consumer staples in 2026. HSY is up nearly 25% this year and has broken out of the bearish trend that began in 2023. Starting in 2023, Hershey grappled with higher cocoa costs that persisted through 2025 and will continue to weigh on earnings in 2026. Still, the market looks forward, and analysts are forecasting solid earnings and revenue growth for the year. HSY currently trades above the consensus price target of $222.21, but analysts have been raising targets since the company's February report. The most bullish call comes from Goldman Sachs, which has a $267 target. In that report Hershey increased its dividend by 5.9%, marking the 15th consecutive annual boost. The dividend yields about 2.5% and the annual payout is $5.81 per share. At more than 50x earnings, HSY's valuation likely prompted heavy institutional selling last quarter, but it may also give investors a chance to buy on a pullback in this sweet, defensive name.
| 
